TwelveStone Partners adds cancer treatments
By HME News Staff
Updated 9:30 AM CDT, Mon October 9, 2023
MURFREESBORO, Tenn. – TwleveStone Partners has expanded its infusion services to include cancer treatments at its Smyrna, Ga., center, with plans to offer the same specialty medications at its Murfreesboro, Tenn., center soon. The ability to provide cancer treatment is possible through innovative medications like Imfinzi for lung and bladder cancer, Rituxan for lymphoma and leukemia, and Opdivo for kidney and bladder cancer that are now available via infusion, the company says. "These new medications offer tremendous hope for those managing a cancer diagnosis," said Shane Reeves, CEO at TwelveStone. "Cancer patients, in particular, deserve the type of holistic care we deliver at TwelveStone focusing on the body, mind and soul." TwelveStone says it is rapidly expanding across the Southeast, anchored by spa-like infusion centers conveniently located in suburban communities and supported by additional services, including package medications, home infusion, enteral and injections.
Comments